GLP-1 drugs, such as ozempic, were originally developed as a tool to help manage blood sugar among people with diabetes
When patients see the same pharmaceutical company name on different medications, they may assume the drugs are related or work similarly
It is a similar compound to semaglutide, the main compound in Ozempic and Wegovy
As Blyumin put it, they were given limited use authorizations to compound these drugs that otherwise they shouldnt be able to, because theyre on patent. Now, those shortages have ended, and compounding pharmacies no longer have a legal basis for producing identical copies of GLP-1s
Yoshinori Abe advises, "GLP-1 users should track body composition, waist size, strength, and metabolic labs rather than weight or BMI alone, since BMI cannot show fat versus muscle." Pay attention to your physical strength as well